Cleveland BioLabs (CBLI -12.5%) gives back some ground this morning after yesterday's +50% surge following the announcement that its treatment for radiation sickness yielded strong survival results in a study of 179 nonhuman primates.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs